Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
12.5
USD
|
+1.87%
|
|
+5.04%
|
+40.45%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
249
|
367.3
|
1,336
|
1,332
|
1,887
|
2,683
|
-
|
-
|
Enterprise Value (EV)
1 |
249
|
339.9
|
1,263
|
1,284
|
1,789
|
2,465
|
2,301
|
2,683
|
P/E ratio
|
-10.5
x
|
-63.5
x
|
-11.3
x
|
-20
x
|
-80.9
x
|
164
x
|
55.8
x
|
36.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.02
x
|
2.47
x
|
4.91
x
|
2.53
x
|
2.16
x
|
2.25
x
|
1.83
x
|
1.48
x
|
EV / Revenue
|
3.02
x
|
2.29
x
|
4.65
x
|
2.44
x
|
2.05
x
|
2.07
x
|
1.57
x
|
1.48
x
|
EV / EBITDA
|
-
|
-41.9
x
|
-42
x
|
-81.4
x
|
36.1
x
|
21.8
x
|
14.2
x
|
11.4
x
|
EV / FCF
|
-
|
-80.6
x
|
-35.8
x
|
-43.9
x
|
31.8
x
|
27.5
x
|
14
x
|
11
x
|
FCF Yield
|
-
|
-1.24%
|
-2.79%
|
-2.28%
|
3.14%
|
3.64%
|
7.15%
|
9.06%
|
Price to Book
|
-
|
-11.6
x
|
3.66
x
|
4.21
x
|
5.42
x
|
6.06
x
|
4.64
x
|
-
|
Nbr of stocks (in thousands)
|
25,156
|
25,156
|
203,913
|
207,739
|
211,994
|
214,649
|
-
|
-
|
Reference price
2 |
9.900
|
14.60
|
6.550
|
6.410
|
8.900
|
12.50
|
12.50
|
12.50
|
Announcement Date
|
10/23/20
|
3/18/21
|
2/22/22
|
2/27/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
82.56
|
148.8
|
271.9
|
526.9
|
872
|
1,193
|
1,466
|
1,812
|
EBITDA
1 |
-
|
-8.114
|
-30.08
|
-15.78
|
49.52
|
113
|
161.6
|
236.2
|
EBIT
1 |
-
|
-15.14
|
-115
|
-68.7
|
-29.45
|
22.78
|
62.43
|
112.8
|
Operating Margin
|
-
|
-10.18%
|
-42.31%
|
-13.04%
|
-3.38%
|
1.91%
|
4.26%
|
6.23%
|
Earnings before Tax (EBT)
1 |
-
|
-17.99
|
-110.8
|
-65.71
|
-21.57
|
31.15
|
71.86
|
122
|
Net income
1 |
-
|
-18.11
|
-107.7
|
-65.68
|
-23.55
|
24.24
|
52.83
|
80.99
|
Net margin
|
-
|
-12.18%
|
-39.6%
|
-12.46%
|
-2.7%
|
2.03%
|
3.6%
|
4.47%
|
EPS
2 |
-0.9400
|
-0.2300
|
-0.5800
|
-0.3200
|
-0.1100
|
0.0761
|
0.2241
|
0.3417
|
Free Cash Flow
1 |
-
|
-4.216
|
-35.24
|
-29.24
|
56.26
|
89.77
|
164.6
|
243
|
FCF margin
|
-
|
-2.83%
|
-12.96%
|
-5.55%
|
6.45%
|
7.53%
|
11.22%
|
13.41%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
113.63%
|
79.45%
|
101.87%
|
102.87%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
370.4%
|
311.57%
|
300.03%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/23/20
|
3/18/21
|
2/22/22
|
2/27/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
74.17
|
84.7
|
101.3
|
113.6
|
144.8
|
167.2
|
190.8
|
207.9
|
226.7
|
246.6
|
268.6
|
285.5
|
304.4
|
322.3
|
334.7
|
EBITDA
1 |
-9.788
|
-7.059
|
-6.061
|
-7.541
|
-6.096
|
3.919
|
6.06
|
10.64
|
12.25
|
20.57
|
23.66
|
25.35
|
27.38
|
31.48
|
36.84
|
EBIT
1 |
-27.66
|
-21.56
|
-16.92
|
-20.19
|
-19.98
|
-11.6
|
-11.26
|
-9.236
|
-8.554
|
-0.4
|
3.929
|
4.007
|
4.318
|
9.658
|
14.23
|
Operating Margin
|
-37.29%
|
-25.46%
|
-16.7%
|
-17.78%
|
-13.8%
|
-6.94%
|
-5.9%
|
-4.44%
|
-3.77%
|
-0.16%
|
1.46%
|
1.4%
|
1.42%
|
3%
|
4.25%
|
Earnings before Tax (EBT)
1 |
-19.11
|
-31.25
|
-16.16
|
-19.67
|
-18.86
|
-11.03
|
-9.681
|
-7.17
|
-6.916
|
2.196
|
5.905
|
6.002
|
6.273
|
11.81
|
15.52
|
Net income
1 |
-15.94
|
-31.16
|
-16.25
|
-19.68
|
-18.84
|
-10.91
|
-10.07
|
-7.157
|
-7.567
|
1.245
|
4.702
|
4.835
|
5.031
|
9.603
|
11.16
|
Net margin
|
-21.49%
|
-36.79%
|
-16.04%
|
-17.33%
|
-13.01%
|
-6.52%
|
-5.28%
|
-3.44%
|
-3.34%
|
0.5%
|
1.75%
|
1.69%
|
1.65%
|
2.98%
|
3.33%
|
EPS
2 |
-0.0800
|
-0.1500
|
-0.0800
|
-0.1000
|
-0.0900
|
-0.0500
|
-0.0500
|
-0.0300
|
-0.0400
|
0.0100
|
0.0102
|
0.0138
|
0.0174
|
0.0305
|
0.0510
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/10/21
|
2/22/22
|
5/9/22
|
8/8/22
|
11/7/22
|
2/27/23
|
5/8/23
|
8/7/23
|
11/6/23
|
2/26/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
27.3
|
72.6
|
47.6
|
97.5
|
218
|
382
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-4.22
|
-35.2
|
-29.2
|
56.3
|
89.8
|
165
|
243
|
ROE (net income / shareholders' equity)
|
-
|
-24.2%
|
-32.2%
|
-20.3%
|
-7.18%
|
7.43%
|
22.6%
|
35.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-16.7%
|
-5.83%
|
6.04%
|
9.89%
|
-
|
Assets
1 |
-
|
-
|
-
|
393.5
|
403.8
|
401.2
|
533.9
|
-
|
Book Value Per Share
2 |
-
|
-1.260
|
1.790
|
1.520
|
1.640
|
2.060
|
2.690
|
-
|
Cash Flow per Share
2 |
-
|
-0.0300
|
-0.1800
|
-0.1300
|
0.3500
|
0.5700
|
0.7500
|
-
|
Capex
1 |
-
|
1.74
|
0.83
|
2.71
|
17.2
|
23.5
|
19.2
|
26.7
|
Capex / Sales
|
-
|
1.17%
|
0.31%
|
0.52%
|
1.97%
|
1.97%
|
1.31%
|
1.47%
|
Announcement Date
|
10/23/20
|
3/18/21
|
2/22/22
|
2/27/23
|
2/26/24
|
-
|
-
|
-
|
Last Close Price
12.5
USD Average target price
14.94
USD Spread / Average Target +19.54% Consensus |
1st Jan change
|
Capi.
|
---|
| +40.45% | 2.68B | | +22.83% | 527M | | +42.77% | 467M | | -64.56% | 156M | | -31.65% | 85.12M |
Telemedicine Services
|